Loading...
Clinical use of the β(3) adrenoceptor agonist mirabegron in patients with overactive bladder syndrome
Mirabegron is a β(3) adrenoceptor agonist licensed for the treatment of overactive bladder symptoms, such as urinary urgency or urgency incontinence. β(3) adrenoceptor activation causes detrusor muscle relaxation, but mirabegron may also act by binding other targets in the bladder, and it may also r...
Na minha lista:
| Udgivet i: | Ther Adv Urol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4549701/ https://ncbi.nlm.nih.gov/pubmed/26425139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215591763 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|